Optimization of the cyclotide framework to improve cell penetration properties

Frontiers in Pharmacology

Volumn 6, Issue FEB, 2015, Pages

  Huang, Yen Hua ^a   Chaousis, Stephanie ^a   Cheneval, Olivier ^a   Craik, David J ^a   Henriques, Sónia T ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cyclic cell penetrating peptide; Cyclotide; Drug delivery; Peptide reengineering; Peptide scaffold

Indexed keywords

CELL PENETRATING PEPTIDE; CYCLOTIDE; MOMORDICA COCHINCHINENSIS TRYPSIN INHIBITOR I; MOMORDICA COCHINCHINENSIS TRYPSIN INHIBITOR II; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; GOLD STANDARD; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; MOMORDICA COCHINCHINENSIS;

EID: 84926505357     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00017     Document Type: Article

References (25)

1. Cascales, L., Henriques, S. T., Kerr, M. C., Huang, Y.-H., Sweet, M. J., Daly, N. L., et al. (2011). Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides. J. Biol. Chem. 286, 36932-36943. doi: 10.1074/jbc. M111.264424
2. Chan, L. Y., Gunasekera, S., Henriques, S. T., Worth, N. F., Le, S.-J., Clark, R. J., et al. (2011). Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood 118, 6709-6717. doi: 10.1182/blood-2011-06-359141
3. Cheneval, O., Schroeder, C. I., Durek, T., Walsh, P., Huang, Y.-H., Liras, S., et al. (2014). Fmoc-based synthesis of disulfide-rich cyclic peptides. J. Org. Chem. 79, 5538-5544. doi: 10.1021/jo500699m
4. Contreras, J., Elnagar, A. Y. O., Hamm-Alvarez, S. F., and Camarero, J. A. (2011). Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways. J. Control. Release 155, 134-143. doi: 10.1016/j.jconrel.2011.08.030
5. Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999). Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol. 294, 1327-1336. doi: 10.1006/jmbi.1999.3383
6. Craik, D. J., Fairlie, D. P., Liras, S., and Price, D. (2013). The future of peptide-based drugs. Chem. Biol. Drug Des. 81, 136-147. doi: 10.1111/cbdd.12055
7. D'Souza, C., Henriques, S. T., Wang, C. K., and Craik, D. J. (2014). Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1. Eur. J. Med. Chem. 88, 10-18. doi: 10.1016/j.ejmech.2014.06.047
8. Eliasen, R., Daly, N. L., Wulff, B. S., Andresen, T. L., Conde-Frieboes, K. W., and Craik, D. J. (2012). Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1. J. Biol. Chem. 287, 40493-40501. doi: 10.1074/jbc. M112.395442
9. Felizmenio-Quimio, M. E., Daly, N. L., and Craik, D. J. (2001). Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis. J. Biol. Chem. 276, 22875-22882. doi: 10.1074/jbc. M101666200
10. Fuchs, S. M., and Raines, R. T. (2006). Internalization of cationic peptides: the road less (or more?) traveled. Cell. Mol. Life Sci. 63, 1819-1822. doi: 10.1007/s00018-006-6170-z
11. Greenwood, K. P., Daly, N. L., Brown, D. L., Stow, J. L., and Craik, D. J. (2007). The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int. J. Biochem. Cell Biol. 39, 2252-2264. doi: 10.1016/j.biocel.2007.06.016
12. Henriques, S. T., and Craik, D. J. (2010). Cyclotides as templates in drug design. Drug Discov. Today 15, 57-64. doi: 10.1016/j.drudis.2009.10.007
13. Henriques, S. T., Melo, M. N., and Castanho, M. A. R. B. (2006). Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399, 1-7. doi: 10.1042/BJ20061100
14. Hoe, K. K., Verma, C. S., and Lane, D. P. (2014). Drugging the p53 pathway: understanding the route to clinical efficacy. Nat. Rev. Drug Discov. 13, 217-236. doi: 10.1038/nrd4236
15. Ji, Y., Majumder, S., Millard, M., Borra, R., Bi, T., Elnagar, A. Y., et al. (2013). In vivo Activation of the p53 tumor suppressor pathway by an engineered cyclotide. J. Am. Chem. Soc. 135, 11623-11633. doi: 10.1021/ja405108p
16. Kim, D., Jeon, C., Kim, J.-H., Kim, M.-S., Yoon, C.-H., Choi, I.-S., et al. (2006). Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo. Exp. Cell Res. 312, 1277-1288. doi: 10.1016/j.yexcr.2005.12.029
17. Poth, A. G., Chan, L. Y., and Craik, D. J. (2013). Cyclotides as grafting frameworks for protein engineering and drug design applications. Biopolymers 100, 480-491. doi: 10.1002/bip.22284
18. Quimbar, P., Malik, U., Sommerhoff, C. P., Kaas, Q., Chan, L. Y., Huang, Y.-H., et al. (2013). High-affinity cyclic peptide matriptase inhibitors. J. Biol. Chem. 288, 13885-13896. doi: 10.1074/jbc. M113.460030
19. Sali, A., and Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815. doi: 10.1006/jmbi.1993.1626
20. Schroeder, C. I., and Craik, D. J. (2012). Therapeutic potential of conopeptides. Future Med. Chem. 4, 1243-1255. doi: 10.4155/fmc.12.70
21. Sundlass, N. K., and Raines, R. T. (2011). Arginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase. Biochemistry 50, 10293-10299. doi: 10.1021/bi200979k
22. Torcato, I. M., Huang, Y.-H., Franquelim, H. G., Gaspar, D., Craik, D. J., Castanho, M. A. R. B., et al. (2013b). Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria. Biochim. Biophys. Acta 1828, 944-955. doi: 10.1016/j.bbamem.2012.12.002
23. Torcato, I. M., Huang, Y.-H., Franquelim, H. G., Gaspar, D. D., Craik, D. J., Castanho, M. A. R. B., et al. (2013a). The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability. Chembiochem 14, 2013-2022. doi: 10.1002/cbic.201300274
24. Wang, C. K., Gruber, C. W., Cemazar, M., Siatskas, C., Tagore, P., Payne, N., et al. (2014). Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS Chem. Biol. 9, 156-163. doi: 10.1021/cb400548s
25. Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., et al. (1995). 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 6, 135-140.